BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 3927302)

  • 1. Expression of histocompatibility antigens H-2K, -D, and -L is reduced in adenovirus-12-transformed mouse cells and is restored by interferon gamma.
    Eager KB; Williams J; Breiding D; Pan S; Knowles B; Appella E; Ricciardi RP
    Proc Natl Acad Sci U S A; 1985 Aug; 82(16):5525-9. PubMed ID: 3927302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumorigenicity of adenovirus-transformed cells: region E1A of adenovirus 12 confers resistance to natural killer cells.
    Sawada Y; Föhring B; Shenk TE; Raska K
    Virology; 1985 Dec; 147(2):413-21. PubMed ID: 3878030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Down-regulation of the major histocompatibility complex class I enhancer in adenovirus type 12-transformed cells is accompanied by an increase in factor binding.
    Ge R; Kralli A; Weinmann R; Ricciardi RP
    J Virol; 1992 Dec; 66(12):6969-78. PubMed ID: 1433502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Region E1a of highly oncogenic adenovirus 12 in transformed cells protects against NK but not LAK cytolysis.
    Kenyon DJ; Raska K
    Virology; 1986 Dec; 155(2):644-54. PubMed ID: 2947382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Driving adenovirus type 12-transformed BALB/c mouse cells to express high levels of class I major histocompatibility complex proteins enhances, rather than abrogates, their tumorigenicity.
    Soddu S; Lewis AM
    J Virol; 1992 May; 66(5):2875-84. PubMed ID: 1313906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. E1A oncogene of adenovirus-12 mediates trans-repression of MHC class I transcription in Ad5/Ad12 somatic hybrid transformed cells.
    Ge R; Liu X; Ricciardi RP
    Virology; 1994 Sep; 203(2):389-92. PubMed ID: 8053163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of adenovirus E1A regions which affect MHC class I expression and susceptibility to cytotoxic T lymphocytes.
    Pereira DS; Rosenthal KL; Graham FL
    Virology; 1995 Aug; 211(1):268-77. PubMed ID: 7645220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellular protein differences between nontumorigenic Ad5 and tumorigenic Ad12 transformed mouse cells.
    Eager KB; Sawicki JA; Ricciardi RP
    Virology; 1986 Jul; 152(2):487-91. PubMed ID: 3727404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adenovirus type 12 early region 1A proteins repress class I HLA expression in transformed human cells.
    Vasavada R; Eager KB; Barbanti-Brodano G; Caputo A; Ricciardi RP
    Proc Natl Acad Sci U S A; 1986 Jul; 83(14):5257-61. PubMed ID: 3014539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adenovirus type 12 specific cell surface antigen in transformed cells is a product of the E1b early region.
    Föhring B; Gallimore PH; Mellow GH; Raska K
    Virology; 1983 Dec; 131(2):463-72. PubMed ID: 6197809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumorigenicity of hamster and mouse cells transformed by adenovirus types 2 and 5 is not influenced by the level of class I major histocompatibility antigens expressed on the cells.
    Haddada H; Lewis AM; Sogn JA; Coligan JE; Cook JL; Walker TA; Levine AS
    Proc Natl Acad Sci U S A; 1986 Dec; 83(24):9684-8. PubMed ID: 3467332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Downregulation of peptide transporter genes in cell lines transformed with the highly oncogenic adenovirus 12.
    Rotem-Yehudar R; Winograd S; Sela S; Coligan JE; Ehrlich R
    J Exp Med; 1994 Aug; 180(2):477-88. PubMed ID: 7519239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Negative regulation of the major histocompatibility complex class I enhancer in adenovirus type 12-transformed cells via a retinoic acid response element.
    Kralli A; Ge R; Graeven U; Ricciardi RP; Weinmann R
    J Virol; 1992 Dec; 66(12):6979-88. PubMed ID: 1433503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential expression of tapasin and immunoproteasome subunits in adenovirus type 5- versus type 12-transformed cells.
    Vertegaal AC; Kuiperij HB; Houweling A; Verlaan M; van der Eb AJ; Zantema A
    J Biol Chem; 2003 Jan; 278(1):139-46. PubMed ID: 12407112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Viral gene inhibition of class I major histocompatibility antigen expression: not a general mechanism governing the tumorigenicity of adenovirus type 2-, adenovirus type 12-, and simian virus 40-transformed Syrian hamster cells.
    Haddada H; Sogn JA; Coligan JE; Carbone M; Dixon K; Levine AS; Lewis AM
    J Virol; 1988 Aug; 62(8):2755-61. PubMed ID: 2839700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adenovirus 12-mediated down-regulation of the major histocompatibility complex (MHC) class I promoter: identification of a negative regulatory element responsive to Ad12 E1A.
    Proffitt JL; Sharma E; Blair GE
    Nucleic Acids Res; 1994 Nov; 22(22):4779-88. PubMed ID: 7984430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A point mutation in the first splice donor leads to reduced oncogenic properties of the adenovirus serotype 12 E1A gene.
    Lehmkühler O; Kühn C; Gunawardena B; Esche H; Brockmann D
    Intervirology; 2003; 46(1):1-16. PubMed ID: 12566694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. E1A-based determinants of oncogenicity in human adenovirus groups A and C.
    Williams JF; Zhang Y; Williams MA; Hou S; Kushner D; Ricciardi RP
    Curr Top Microbiol Immunol; 2004; 273():245-88. PubMed ID: 14674604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dependence of tumor-forming capacities of cells transformed by recombinants between adenovirus types 5 and 12 on expression of early region 1.
    Shiroki K; Maruyama K; Saito I; Fukui Y; Yazaki K; Shimojo H
    J Virol; 1982 May; 42(2):708-18. PubMed ID: 7086973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumorigenicity of adenovirus-transformed rodent cells is influenced by at least two regions of adenovirus type 12 early region 1A.
    Jelinek T; Pereira DS; Graham FL
    J Virol; 1994 Feb; 68(2):888-96. PubMed ID: 8289391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.